Global Opthalmic Therapeutics Market Size, Status and Forecast 2022

Publisher Name :
Date: 27-Jul-2017
No. of pages: 100
Inquire Before Buying

This report studies the global Opthalmic Therapeutics market, analyzes and researches the Opthalmic Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

- Pfizer

- Novartis

- GlaxoSmithKline

- Alcon

- Merck

- F. Hoffmann-La Roche

- Bayer

- Actavis

- Boehringer Ingelheim

- R-Tech Ueno

- Valeant Pharmaceuticals

- Regeneron Pharmaceuticals

- Acadia Pharmaceuticals

- Allergan

- Falcon Pharmaceuticals

- Otsuka Pharmaceutical

- Senju Pharmaceutical

- OPKO Health

- Lexicon Pharmaceuticals

Market segment by Regions/Countries, this report covers

- United States

- EU

- Japan

- China

- India

- Southeast Asia

Market segment by Type, Opthalmic Therapeutics can be split into

- Oral

- Injection

- External Application

Market segment by Application, Opthalmic Therapeutics can be split into

- Hospitals

- Clinics

- Home Care Settings

- Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Opthalmic Therapeutics Market Size, Status and Forecast 2022

Table of Contents
Global Opthalmic Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Opthalmic Therapeutics
1.1 Opthalmic Therapeutics Market Overview
1.1.1 Opthalmic Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Opthalmic Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Opthalmic Therapeutics Market by Type
1.3.1 Oral
1.3.2 Injection
1.3.3 External Application
1.4 Opthalmic Therapeutics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Home Care Settings
1.4.4 Other
2 Global Opthalmic Therapeutics Competition Analysis by Players
2.1 Opthalmic Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Novartis
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GlaxoSmithKline
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Alcon
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Merck
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 F. Hoffmann-La Roche
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Bayer
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Actavis
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Boehringer Ingelheim
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 R-Tech Ueno
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Opthalmic Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Valeant Pharmaceuticals
3.12 Regeneron Pharmaceuticals
3.13 Acadia Pharmaceuticals
3.14 Allergan
3.15 Falcon Pharmaceuticals
3.16 Otsuka Pharmaceutical
3.17 Senju Pharmaceutical
3.18 OPKO Health
3.19 Lexicon Pharmaceuticals
4 Global Opthalmic Therapeutics Market Size by Type and Application (2012-2017)
4.1 Global Opthalmic Therapeutics Market Size by Type (2012-2017)
4.2 Global Opthalmic Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Opthalmic Therapeutics in Future
4.4 Top Consumer/End Users of Opthalmic Therapeutics
5 United States Opthalmic Therapeutics Development Status and Outlook
5.1 United States Opthalmic Therapeutics Market Size (2012-2017)
5.2 United States Opthalmic Therapeutics Market Size and Market Share by Players (2016 and 2017)
6 EU Opthalmic Therapeutics Development Status and Outlook
6.1 EU Opthalmic Therapeutics Market Size (2012-2017)
6.2 EU Opthalmic Therapeutics Market Size and Market Share by Players (2016 and 2017)
7 Japan Opthalmic Therapeutics Development Status and Outlook
7.1 Japan Opthalmic Therapeutics Market Size (2012-2017)
7.2 Japan Opthalmic Therapeutics Market Size and Market Share by Players (2016 and 2017)
8 China Opthalmic Therapeutics Development Status and Outlook
8.1 China Opthalmic Therapeutics Market Size (2012-2017)
8.2 China Opthalmic Therapeutics Market Size and Market Share by Players (2016 and 2017)
9 India Opthalmic Therapeutics Development Status and Outlook
9.1 India Opthalmic Therapeutics Market Size (2012-2017)
9.2 India Opthalmic Therapeutics Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Opthalmic Therapeutics Development Status and Outlook
10.1 Southeast Asia Opthalmic Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Opthalmic Therapeutics Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Opthalmic Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Opthalmic Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Opthalmic Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Opthalmic Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Opthalmic Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Opthalmic Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Opthalmic Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Opthalmic Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Opthalmic Therapeutics Market Size by Application (2017-2022)
12 Opthalmic Therapeutics Market Dynamics
12.1 Opthalmic Therapeutics Market Opportunities
12.2 Opthalmic Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Opthalmic Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Opthalmic Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Opthalmic Therapeutics Product Scope
Figure Global Opthalmic Therapeutics Market Size (Million USD) (2012-2017)
Table Global Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Opthalmic Therapeutics Market Share by Regions in 2016
Figure United States Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Opthalmic Therapeutics Market Share by Type in 2016
Figure Oral Market Size (Million USD) and Growth Rate (2012-2017)
Figure Injection Market Size (Million USD) and Growth Rate (2012-2017)
Figure External Application Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Opthalmic Therapeutics Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Opthalmic Therapeutics Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Opthalmic Therapeutics Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Home Care Settings
Figure Opthalmic Therapeutics Market Size (Million USD) and Growth Rate in Home Care Settings (2012-2017)
Table Key Downstream Customer in Other
Figure Opthalmic Therapeutics Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Opthalmic Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Opthalmic Therapeutics Market Size Share by Players in 2016
Figure Opthalmic Therapeutics Market Size Share by Players in 2017
Table Pfizer Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Opthalmic Therapeutics Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Alcon Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Alcon (2012-2017)
Figure Alcon Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Opthalmic Therapeutics Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Bayer Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Bayer (2012-2017)
Figure Bayer Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Actavis Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Actavis (2012-2017)
Figure Actavis Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Opthalmic Therapeutics Business Revenue Market Share in 2016
Table R-Tech Ueno Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of R-Tech Ueno (2012-2017)
Figure R-Tech Ueno Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Valeant Pharmaceuticals Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Valeant Pharmaceuticals (2012-2017)
Figure Valeant Pharmaceuticals Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Regeneron Pharmaceuticals Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Regeneron Pharmaceuticals (2012-2017)
Figure Regeneron Pharmaceuticals Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Acadia Pharmaceuticals Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Acadia Pharmaceuticals (2012-2017)
Figure Acadia Pharmaceuticals Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Allergan Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Allergan (2012-2017)
Figure Allergan Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Falcon Pharmaceuticals Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Falcon Pharmaceuticals (2012-2017)
Figure Falcon Pharmaceuticals Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Otsuka Pharmaceutical Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Otsuka Pharmaceutical (2012-2017)
Figure Otsuka Pharmaceutical Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Senju Pharmaceutical Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Senju Pharmaceutical (2012-2017)
Figure Senju Pharmaceutical Opthalmic Therapeutics Business Revenue Market Share in 2016
Table OPKO Health Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of OPKO Health (2012-2017)
Figure OPKO Health Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Lexicon Pharmaceuticals Basic Information List
Table Opthalmic Therapeutics Business Revenue (Million USD) of Lexicon Pharmaceuticals (2012-2017)
Figure Lexicon Pharmaceuticals Opthalmic Therapeutics Business Revenue Market Share in 2016
Table Global Opthalmic Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Opthalmic Therapeutics Market Size Share by Type in 2012
Figure Global Opthalmic Therapeutics Market Size Share by Type in 2013
Figure Global Opthalmic Therapeutics Market Size Share by Type in 2014
Figure Global Opthalmic Therapeutics Market Size Share by Type in 2015
Figure Global Opthalmic Therapeutics Market Size Share by Type in 2016
Figure Global Opthalmic Therapeutics Market Size Share by Type in 2017
Table Global Opthalmic Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Opthalmic Therapeutics
Figure United States Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Opthalmic Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Opthalmic Therapeutics Market Size Share by Players in 2016
Figure United States Opthalmic Therapeutics Market Size Share by Players in 2017
Figure EU Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Opthalmic Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Opthalmic Therapeutics Market Size Share by Players in 2016
Figure EU Opthalmic Therapeutics Market Size Share by Players in 2017
Figure Japan Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Opthalmic Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Opthalmic Therapeutics Market Size Share by Players in 2016
Figure Japan Opthalmic Therapeutics Market Size Share by Players in 2017
Figure China Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Opthalmic Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Opthalmic Therapeutics Market Size Share by Players in 2016
Figure China Opthalmic Therapeutics Market Size Share by Players in 2017
Figure India Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Opthalmic Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Opthalmic Therapeutics Market Size Share by Players in 2016
Figure India Opthalmic Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Opthalmic Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Opthalmic Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Opthalmic Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Opthalmic Therapeutics Market Size Share by Players in 2017
Figure Global Opthalmic Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Opthalmic Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Opthalmic Therapeutics Market Size Share by Regions in 2017
Figure Global Opthalmic Therapeutics Market Size Share by Regions in 2022
Figure United States Opthalmic Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Opthalmic Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Opthalmic Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Opthalmic Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Opthalmic Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Opthalmic Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Opthalmic Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Opthalmic Therapeutics Market Size Share by Type in 2017
Figure Global Opthalmic Therapeutics Market Size Share by Type in 2022
Table Global Opthalmic Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Opthalmic Therapeutics Market Size (Million USD) by Application in 2022
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 72
    C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017 Summary C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2017, outlays comprehensive info......
  • C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 59
    C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017 Summary C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - CXCR2 or Interleukin 8 receptor, beta is a chemokine receptor. It binds to IL8 with high affinity, and transduces the signal through a G-prot......
  • C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 54
    C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017 Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes. The latest report C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017, outlays comprehensive information on the C5a Anaphylato......
  • Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 53
    Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017 Summary Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Prostaglandin D2 (PGD2) receptors are G protein-coupled receptors that binds and is activated by prostaglandin D2. ......
  • Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 45
    Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017 Summary According to the recently published report 'Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2017'; Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. ......
  • Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 74
    Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017 Summary Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) pipeline Target constitutes close to 17 molecules. Out of which approximately 17 molecules are developed by Companies. The lat......
  • Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 49
    Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2017 Summary Glucagon Like Peptide 2 Receptor (GLP2R) - Glucagon-like peptide 2 receptor (GLP-2R) is a protein encoded by the GLP2R gene. GLP2R, a G protein-coupled receptor superfamily member is expressed in the gut. GLP2 stimulates intestinal growth and up regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. GLP2 prevent......
  • Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 55
    Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017 Summary According to the recently published report 'Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017'; Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) pipeline Target constitutes close to 14 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. M......
  • Restenosis - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 48
    Restenosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis - Pipeline Review, H2 2017, provides an overview of the Restenosis (Cardiovascular) pipeline landscape. Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty walking and chest pain. Risk factors include increasing age, gender, family hist......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs